Germline elongator protein complex (ELP1) mutations confer susceptibility to SHH-activated TP53 wild-type medulloblastomas in pediatric populations, which are defined as “ELP1-medulloblastoma syndrome” [27]. The gene discussed is TP53; the disease is medulloblastoma.